Diagnosis of asthma and permitted use of inhaled β2-agonists in athletes (vol 59, pg 33, 2004)

被引：1

|

作者：

Bonini, S

Brusasco, V

Carlsen, KH

Delgado, L

Del Giacco, SR

Haahtela, T

Rasi, G

Cauwenberge, PB

机构：

来源：

ALLERGY | 2005年 / 60卷 / 04期

关键词：

D O I：

10.1111/j.1398-9995.2005.00838.x

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：548 / 548

页数：1

相关论文

共 50 条

[1] Diagnosis of asthma and permitted use of inhaled β2-agonists in athletes
Bonini, S
Brusasco, V
Carlsen, KH
Delgado, L
Giacco, SD
Haahtela, T
Rasi, G
van Cauwenberge, PB
ALLERGY, 2004, 59 (01) : 33 - 36
[2] Why must Olympic athletes prove that they have asthma to be permitted to take inhaled β2-agonists?
Weiler, JM
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (01) : 36 - 37
[3] Clinical concerns with inhaled β2-agonists -: Adult asthma
Cockcroft, D. W.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2006, 31 (2-3) : 197 - 207
[4] Long-acting inhaled β2-agonists in asthma therapy
Moore, RH
Khan, A
Dickey, BF
CHEST, 1998, 113 (04) : 1095 - 1108
[5] Step one for asthma treatment -: β2-agonists or inhaled corticosteroids?
Redington, AE
DRUGS, 2001, 61 (09) : 1231 - 1238
[6] Step One for Asthma Treatmentβ2-Agonists or Inhaled Corticosteroids?
Anthony E. Redington
Drugs, 2001, 61 : 1231 - 1238
[7] Ergogenic Effects of Inhaled β2-Agonists in Non-Asthmatic Athletes
Wolfarth, Bernd
Wuestenfeld, Jan C.
Kindermann, Wilfried
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2010, 39 (01) : 75 - +
[8] Ambulatory use of inhaled β2-agonists for the treatment of asthma in Quebec -: A population-based utilization review
Blais, R
Grégoire, JP
Rouleau, R
Cartier, A
Bouchard, J
Boulet, LP
CHEST, 2001, 119 (05) : 1316 - 1321
[9] Long-acting inhaled β2-agonists for stable COPD (vol 37, pg 1247, 2003)
Dougherty, JA
ANNALS OF PHARMACOTHERAPY, 2004, 38 (03) : 513 - 513
[10] Patients with asthma should use intermediate-acting inhaled β2-agonists only on an as-needed basis
Drugs & Therapy Perspectives, 2006, 22 (1) : 12 - 13

← 1 2 3 4 5 →